Faron at Canaccord Oncology Virtual Conference
Faron Pharmaceuticals Oy (“Faron” or the “Company”) Faron to Present at Canaccord Horizons in Oncology Virtual Conference Press release, April 13, 2023 TURKU, FINLAND / BOSTON, MA - Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on tackling cancers via immunotherapy, today announces that Chief Executive Officer, Dr. Markku Jalkanen and Chief Medical Officer, Dr. Marie-Louise Fjällskog, will present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 20 at 8 AM EST.